Systemically administered zoledronic acid activates locally implanted synthetic hydroxyapatite particles enhancing peri-implant bone formation: A regenerative medicine approach to improve fracture fixation.
Markeviciute V, Puthia M, Arvidsson L, Liu Y, Törnquist E, Tengattini A, Huang J, Bai Y, Vater C, Petrolis R, Zwingenberger S, Krisciukaitis A, Smailys A, Lukosevicius S, Stravinskas M, Isaksson H, Tarasevicius S, Lidgren L, Tägil M, Raina DB.
Markeviciute V, et al. Among authors: krisciukaitis a.
Acta Biomater. 2024 Mar 13:S1742-7061(24)00124-7. doi: 10.1016/j.actbio.2024.03.005. Online ahead of print.
Acta Biomater. 2024.
PMID: 38490481
Free article.